Detalles de la búsqueda
1.
Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI).
Lung Cancer
; 113: 79-84, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29110854
2.
Rituximab with or without bevacizumab for the treatment of patients with relapsed follicular lymphoma.
Clin Lymphoma Myeloma Leuk
; 14(4): 277-83, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24679633
3.
Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.
J Clin Oncol
; 31(2): 217-23, 2013 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23032625
4.
Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer.
Lung Cancer
; 77(2): 359-64, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22560921
Resultados
1 -
4
de 4
1
Próxima >
>>